Signature Equity Partners’s Qiagen QGEN Stock Holding History

Signature Equity Partners’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$40	–	1678
2026 Q1	$40	Sell	1 -1	-50%	-$47	﹤0.01%	1545
2025 Q4	$90	Buy	+2	New	+$93	﹤0.01%	1681

Other funds holding QGEN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Signature Equity Partners's QGEN Position: Q2 2026 in Review

Signature Equity Partners sold out of Qiagen (QGEN) in Q2 2026, closing a stake of 1 share — an estimated $40 sold.

Signature Equity Partners first reported a position in QGEN in Q4 2025 and held it in 2 quarters. The position peaked at $90 in Q4 2025. 336 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

Signature Equity Partners reported no remaining Qiagen position as of Q2 2026 after selling out during the quarter.
Signature Equity Partners sold 1 Qiagen share in Q2 2026, an estimated $40.
Signature Equity Partners first reported a position in Qiagen in Q4 2025 and held it in 2 quarters.
Signature Equity Partners's Qiagen position peaked at $90 in Q4 2025.
336 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.